EG vs RGEN · P/E 17, rev $8.03B vs P/E 143, rev $204.1M
Everest Group Ltd (EG) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
EG currently screens at market cap $14.52B and trailing P/E 17.2. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the EG and RGEN stock pages for the full models.
Not investment advice.